FCM
TYRA icon

Farallon Capital Management’s Tyra Biosciences TYRA Stock Holding History

Farallon Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137M Buy
3,580,818
+1,514,000
+73% +$49M 0.78% 34
2025
Q4 		$54.3M Buy
2,066,818
+923,000
+81% +$17M 0.25% 52
2025
Q3 		$16M Hold
1,143,818
– – 0.07% 73
2025
Q2 		$10.9M Hold
1,143,818
– – 0.05% 81
2025
Q1 		$10.6M Buy
1,143,818
+142,837
+14% +$1.85M 0.05% 74
2024
Q4 		$13.9M Buy
+1,000,981
New +$18.2M 0.06% 78

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Farallon Capital Management's TYRA Position: Q1 2026 in Review

Farallon Capital Management increased its Tyra Biosciences (TYRA) stake by 73% in Q1 2026, buying an estimated $49M and bringing the position to 3,580,818 shares worth $137M. The position accounts for 0.78% of the portfolio, ranked #34.

Farallon Capital Management first reported a position in TYRA in Q4 2024 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Farallon Capital Management held 3,580,818 shares of Tyra Biosciences worth $137M as of Q1 2026.
  • Farallon Capital Management bought 1,514,000 Tyra Biosciences shares in Q1 2026, an estimated $49M.
  • Tyra Biosciences made up 0.78% of Farallon Capital Management's portfolio in Q1 2026, its #34 holding.
  • Farallon Capital Management first reported a position in Tyra Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.